Neuropsychiatric symptoms in a patient diagnosed in adulthood with Metachromatic Leukodystrophy: Case report of low incidence and prevalence in Colombia

La leucodistrofia metacromática (MLD) es una patología crónica de baja prevalencia y baja incidencia a nivel mundial, se caracteriza por presentar alteraciones en la sustancia blanca del sistema nervioso central (SNC), resultado de una deficiencia de la Arilsulfatasa A (ARSA). enzima que se encarga...

Full description

Autores:
Hurtado González, Carlos Alberto
Cordoba, A.
Alvear, L.
Ramos, G. E.
CINEPSIS
SEMINEC
Tipo de recurso:
Article of investigation
Fecha de publicación:
2019
Institución:
Universidad Cooperativa de Colombia
Repositorio:
Repositorio UCC
Idioma:
OAI Identifier:
oai:repository.ucc.edu.co:20.500.12494/33682
Acceso en línea:
https://hdl.handle.net/20.500.12494/33682
Palabra clave:
Atención
Funcionamiento neurocognitivo
Funciones ejecutivas
Memoria
Leucodistrofia metacromática
Attention
Neurocognitive Functioning
Executive Functions
Memory
Metachromatic Leukodystrophy
Rights
closedAccess
License
NINGUNA
id COOPER2_bf6de1332313684bdc2bf16070f512fd
oai_identifier_str oai:repository.ucc.edu.co:20.500.12494/33682
network_acronym_str COOPER2
network_name_str Repositorio UCC
repository_id_str
dc.title.spa.fl_str_mv Neuropsychiatric symptoms in a patient diagnosed in adulthood with Metachromatic Leukodystrophy: Case report of low incidence and prevalence in Colombia
title Neuropsychiatric symptoms in a patient diagnosed in adulthood with Metachromatic Leukodystrophy: Case report of low incidence and prevalence in Colombia
spellingShingle Neuropsychiatric symptoms in a patient diagnosed in adulthood with Metachromatic Leukodystrophy: Case report of low incidence and prevalence in Colombia
Atención
Funcionamiento neurocognitivo
Funciones ejecutivas
Memoria
Leucodistrofia metacromática
Attention
Neurocognitive Functioning
Executive Functions
Memory
Metachromatic Leukodystrophy
title_short Neuropsychiatric symptoms in a patient diagnosed in adulthood with Metachromatic Leukodystrophy: Case report of low incidence and prevalence in Colombia
title_full Neuropsychiatric symptoms in a patient diagnosed in adulthood with Metachromatic Leukodystrophy: Case report of low incidence and prevalence in Colombia
title_fullStr Neuropsychiatric symptoms in a patient diagnosed in adulthood with Metachromatic Leukodystrophy: Case report of low incidence and prevalence in Colombia
title_full_unstemmed Neuropsychiatric symptoms in a patient diagnosed in adulthood with Metachromatic Leukodystrophy: Case report of low incidence and prevalence in Colombia
title_sort Neuropsychiatric symptoms in a patient diagnosed in adulthood with Metachromatic Leukodystrophy: Case report of low incidence and prevalence in Colombia
dc.creator.fl_str_mv Hurtado González, Carlos Alberto
Cordoba, A.
Alvear, L.
Ramos, G. E.
CINEPSIS
SEMINEC
dc.contributor.author.none.fl_str_mv Hurtado González, Carlos Alberto
Cordoba, A.
Alvear, L.
Ramos, G. E.
CINEPSIS
SEMINEC
dc.subject.spa.fl_str_mv Atención
Funcionamiento neurocognitivo
Funciones ejecutivas
Memoria
Leucodistrofia metacromática
topic Atención
Funcionamiento neurocognitivo
Funciones ejecutivas
Memoria
Leucodistrofia metacromática
Attention
Neurocognitive Functioning
Executive Functions
Memory
Metachromatic Leukodystrophy
dc.subject.other.spa.fl_str_mv Attention
Neurocognitive Functioning
Executive Functions
Memory
Metachromatic Leukodystrophy
description La leucodistrofia metacromática (MLD) es una patología crónica de baja prevalencia y baja incidencia a nivel mundial, se caracteriza por presentar alteraciones en la sustancia blanca del sistema nervioso central (SNC), resultado de una deficiencia de la Arilsulfatasa A (ARSA). enzima que se encarga de catalizar diferentes reacciones químicas en todo el organismo. Se ha encontrado que la MLD está clínicamente relacionada con una deficiencia del funcionamiento neurocognitivo, especialmente en tareas de memoria (memoria operativa) y en funciones ejecutivas (fluidez verbal semántica, inhibición, planificación y control de la conducta inmediata). Objetivo: Identificar el deterioro neurocognitivo y los síntomas neuropsiquiátricos en un paciente diagnosticado de MLD. Reporte de caso de baja prevalencia e incidencia en Colombia. Metodología: Participante: Paciente de sexo femenino de 60 años, soltera, diestra y docente con pérdida progresiva de la memoria reciente, acompañada de inestabilidad postural, alteración de la marcha, problemas de equilibrio y alteraciones moderadas a severas de tipo neurocognitivo y afectivo. Resultados: Se encontró que la paciente presenta alteraciones ejecutivas (lóbulo frontal) en la toma de decisiones, planificación, inhibición y en la memoria operativa, correlacionadas con una alteración severa en sus actividades básicas, instrumentales y avanzadas de la vida diaria. Conclusión: Es necesario realizar planes funcionales de neurorrehabilitación para personas diagnosticadas de LDM, teniendo como principal objetivo la mejora de su calidad de vida en los aspectos individual, social y familiar.
publishDate 2019
dc.date.issued.none.fl_str_mv 2019-09
dc.date.accessioned.none.fl_str_mv 2021-03-19T20:21:19Z
dc.date.available.none.fl_str_mv 2021-03-19T20:21:19Z
dc.type.none.fl_str_mv Artículos Científicos
dc.type.hasVersion.none.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.coar.none.fl_str_mv http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.coarversion.none.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.driver.none.fl_str_mv info:eu-repo/semantics/article
format http://purl.org/coar/resource_type/c_2df8fbb1
status_str publishedVersion
dc.identifier.issn.spa.fl_str_mv 09070-938X
dc.identifier.uri.none.fl_str_mv https://hdl.handle.net/20.500.12494/33682
dc.identifier.bibliographicCitation.spa.fl_str_mv Cordoba, A., Alvear L., Hurtado-González, C. A., Ramos, G., CINEPSIS y SEMINEC. Neuropsychiatric symptoms in a patient diagnosed in adulthood with Metachromatic Leukodystrophy: Case report of low incidence and prevalence in Colombia. Biomedical Research 2020; 30 (6), 858-863
identifier_str_mv 09070-938X
Cordoba, A., Alvear L., Hurtado-González, C. A., Ramos, G., CINEPSIS y SEMINEC. Neuropsychiatric symptoms in a patient diagnosed in adulthood with Metachromatic Leukodystrophy: Case report of low incidence and prevalence in Colombia. Biomedical Research 2020; 30 (6), 858-863
url https://hdl.handle.net/20.500.12494/33682
dc.relation.isversionof.spa.fl_str_mv https://www.alliedacademies.org/articles/neuropsychiatric-symptoms-in-a-patient-diagnosed-in-adulthood-withmetachromatic-leukodystrophy-case-report-of-low-incidence-and-pr-11602.html
dc.relation.ispartofjournal.spa.fl_str_mv Biomedical Research
dc.relation.references.spa.fl_str_mv Babcock, H. An experiment in the measurement of mental deterioration. Arch Psychol 1930; 117: 105
Beck A, Steer R. Manual BAI. Inventario de Ansiedad de Beck. 2011.
Cacho J, García-García R, Arcaya J, Vicente JL, Lantada N. Una propuesta de aplicación del test del reloj en la enfermedad de Alzheimer. Revista de Neurología 1999; 28: 648-655.
Cummings JL, Victoroff JL. Noncognitive neuropsychiatric syndromes in Alzheimer's disease. Neuropsychiatry Neuropsychol Behav Neurol 1990; 3: 140-158
Dubois B, Slachevsky A, Litvan I, Pillon BF. The FAB A frontal assessment battery at bedside. Neurology 2000; 55: 1621-1626.
Hara K, Shiga A, Fukutake T, Nozaki H, Miyashita A, Yokoseki A, Kawata H, Koyama A, Arima K, Takahashi T, Ikeda M. Association of HTRA1 Mutations and Familial Ischemic Cerebral Small-Vessel Disease. N Engl J Med 2009; 360: 1729-139.
Lawton MP, Brody EM, Saperstein AR. A controlled study of respite service for caregivers of Alzheimer's patients. Gerontologist 1989; 29: 8-16
Lobo A, Pérez-Echeverría MJ, Artal J. Validity of the scaled version of the General Health Questionnaire (GHQ-28) in a Spanish population. Psychol Med 1986; 16: 135-140.
Lobo A, Saz P, Marcos G. Mini-Mental Status Examination. Rev Esp Med Legal 2011; 37: 122-127.
Mahoney F. Funcionales de evaluación: El índice de Barthel. Del Estado de Maryl Med J 1965; 14: 51-65
Nasreddine ZS, Phillips NA, Badirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H. The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005; 53: 695-699.
Rademakers R, Baker M, Nicholson AM, Rutherford NJ, Finch N, Soto-Ortolaza A, Lash J, Wider C, Wojtas A, DeJesus-Hernandez M, Adamson J. Mutations in the colony stimulating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroids. Nature Genetics. 2012; 44: 200-205
Reitan, Ralph M. Trail Making Test: Manual for administration and scoring. Reitan Neuropsychology Laboratory 1992.
Shapiro EG, Lipton ME, Krivit W. White matter dysfunction and its neuropsychological correlates: a longitudinal study of a case of metachromatic leukodystrophy treated with bone marrow transplant. J Clin Exp Neuropsychol 1992; 14: 610-624.
Smith NJ, Marcus RE, Sahakian BJ, Kapur N, Cox TM. Haematopoietic stem cell transplantation does not retard disease progression in the psycho-cognitive variant of late-onset metachromatic leukodystrophy. J Inherit Metab Dis 2010; 33: 471-475
Stroobants S, Leroy T, Eckhardt M, Aerts JM, Berckmans D, D?Hooge R. Early signs of neurolipidosis-related behavioural alterations in a murine model of metachromatic leukodystrophy. Behav Brain Res 2008: 189; 306-316.
Weschsler D. Weschsler Memory Scale. The Psychological Corporation. 1972.
Yesavage JA, Sheikh JI. 9/Geriatric depression scale (GDS) recent evidence and development of a shorter version. Clin Gerontol 1986; 5: 165-173.
dc.rights.license.none.fl_str_mv NINGUNA
dc.rights.accessrights.none.fl_str_mv info:eu-repo/semantics/closedAccess
dc.rights.coar.none.fl_str_mv http://purl.org/coar/access_right/c_14cb
rights_invalid_str_mv NINGUNA
http://purl.org/coar/access_right/c_14cb
eu_rights_str_mv closedAccess
dc.format.extent.spa.fl_str_mv 858-863
dc.coverage.temporal.spa.fl_str_mv 30 (6)
dc.publisher.spa.fl_str_mv Universidad Cooperativa de Colombia, Facultad de Ciencias Sociales, Psicología, Cali
dc.publisher.program.spa.fl_str_mv Psicología
dc.publisher.place.spa.fl_str_mv Cali
institution Universidad Cooperativa de Colombia
bitstream.url.fl_str_mv https://repository.ucc.edu.co/bitstreams/3597a46e-07a1-4c3d-9710-80e28f6a52a3/download
https://repository.ucc.edu.co/bitstreams/7bb37ab6-49e6-48fc-b375-70c07145d94b/download
https://repository.ucc.edu.co/bitstreams/70c22c4c-e67d-4e9e-ac1a-ffb55afca912/download
https://repository.ucc.edu.co/bitstreams/abb70cab-d986-4bb5-b61f-9d0525c700fa/download
bitstream.checksum.fl_str_mv 8f404167f7784e4f60f56b9888b0d783
3bce4f7ab09dfc588f126e1e36e98a45
fee8fada1d8ed7781650ef91340f2662
49b8b699a4c49a6022ec164e1f43eff9
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
repository.name.fl_str_mv Repositorio Institucional Universidad Cooperativa de Colombia
repository.mail.fl_str_mv bdigital@metabiblioteca.com
_version_ 1811565528422023168
spelling Hurtado González, Carlos AlbertoCordoba, A.Alvear, L.Ramos, G. E.CINEPSISSEMINEC30 (6)2021-03-19T20:21:19Z2021-03-19T20:21:19Z2019-0909070-938Xhttps://hdl.handle.net/20.500.12494/33682Cordoba, A., Alvear L., Hurtado-González, C. A., Ramos, G., CINEPSIS y SEMINEC. Neuropsychiatric symptoms in a patient diagnosed in adulthood with Metachromatic Leukodystrophy: Case report of low incidence and prevalence in Colombia. Biomedical Research 2020; 30 (6), 858-863La leucodistrofia metacromática (MLD) es una patología crónica de baja prevalencia y baja incidencia a nivel mundial, se caracteriza por presentar alteraciones en la sustancia blanca del sistema nervioso central (SNC), resultado de una deficiencia de la Arilsulfatasa A (ARSA). enzima que se encarga de catalizar diferentes reacciones químicas en todo el organismo. Se ha encontrado que la MLD está clínicamente relacionada con una deficiencia del funcionamiento neurocognitivo, especialmente en tareas de memoria (memoria operativa) y en funciones ejecutivas (fluidez verbal semántica, inhibición, planificación y control de la conducta inmediata). Objetivo: Identificar el deterioro neurocognitivo y los síntomas neuropsiquiátricos en un paciente diagnosticado de MLD. Reporte de caso de baja prevalencia e incidencia en Colombia. Metodología: Participante: Paciente de sexo femenino de 60 años, soltera, diestra y docente con pérdida progresiva de la memoria reciente, acompañada de inestabilidad postural, alteración de la marcha, problemas de equilibrio y alteraciones moderadas a severas de tipo neurocognitivo y afectivo. Resultados: Se encontró que la paciente presenta alteraciones ejecutivas (lóbulo frontal) en la toma de decisiones, planificación, inhibición y en la memoria operativa, correlacionadas con una alteración severa en sus actividades básicas, instrumentales y avanzadas de la vida diaria. Conclusión: Es necesario realizar planes funcionales de neurorrehabilitación para personas diagnosticadas de LDM, teniendo como principal objetivo la mejora de su calidad de vida en los aspectos individual, social y familiar.The metachromatic leukodystrophy (MLD) is a chronic pathology of low prevalence and low worldwide incidence, it is characterized by presenting alterations in the white substance of the central nervous system (CNS), result of a deficiency of the Arylsulfatase A (ARSA) enzyme which is responsible for catalyzing different chemical reactions throughout the organism. It is been found that MLD is clinically related to a deficiency of the neurocognitive functioning, especially in memory tasks (operative memory) and in executive functions (verbal semantic fluency, inhibition, planning and control of the immediate conduct). Objective: Identify the neurocognitive impairment and the neuropsychiatric symptoms in a patient diagnosed with MLD. Case report of low prevalence and incidence in Colombia. Methodology: Participant: Sixty aged female patient, single, right handed person and a teacher with a progressive loss of recent memory, accompanied with postural instability, gait disturbance, balance problems and moderate to severe alterations of neurocognitive and affective type. Results: It is been found that the patient presents executive alterations (frontal lobe) in decisionmaking, planning, inhibition and in operative memory, correlated to a severe alteration in her basic, instrumental and advanced activities of daily life. Conclusion: It is necessary to make neuro-rehabilitation functional plans for people diagnosed with MLD, having as a main objective the improvement of their quality of life in individual, social and family aspects.carlos.hurtadog@campusucc.edu.co858-863Universidad Cooperativa de Colombia, Facultad de Ciencias Sociales, Psicología, CaliPsicologíaCalihttps://www.alliedacademies.org/articles/neuropsychiatric-symptoms-in-a-patient-diagnosed-in-adulthood-withmetachromatic-leukodystrophy-case-report-of-low-incidence-and-pr-11602.htmlBiomedical ResearchBabcock, H. An experiment in the measurement of mental deterioration. Arch Psychol 1930; 117: 105Beck A, Steer R. Manual BAI. Inventario de Ansiedad de Beck. 2011.Cacho J, García-García R, Arcaya J, Vicente JL, Lantada N. Una propuesta de aplicación del test del reloj en la enfermedad de Alzheimer. Revista de Neurología 1999; 28: 648-655.Cummings JL, Victoroff JL. Noncognitive neuropsychiatric syndromes in Alzheimer's disease. Neuropsychiatry Neuropsychol Behav Neurol 1990; 3: 140-158Dubois B, Slachevsky A, Litvan I, Pillon BF. The FAB A frontal assessment battery at bedside. Neurology 2000; 55: 1621-1626.Hara K, Shiga A, Fukutake T, Nozaki H, Miyashita A, Yokoseki A, Kawata H, Koyama A, Arima K, Takahashi T, Ikeda M. Association of HTRA1 Mutations and Familial Ischemic Cerebral Small-Vessel Disease. N Engl J Med 2009; 360: 1729-139.Lawton MP, Brody EM, Saperstein AR. A controlled study of respite service for caregivers of Alzheimer's patients. Gerontologist 1989; 29: 8-16Lobo A, Pérez-Echeverría MJ, Artal J. Validity of the scaled version of the General Health Questionnaire (GHQ-28) in a Spanish population. Psychol Med 1986; 16: 135-140.Lobo A, Saz P, Marcos G. Mini-Mental Status Examination. Rev Esp Med Legal 2011; 37: 122-127.Mahoney F. Funcionales de evaluación: El índice de Barthel. Del Estado de Maryl Med J 1965; 14: 51-65Nasreddine ZS, Phillips NA, Badirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H. The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005; 53: 695-699.Rademakers R, Baker M, Nicholson AM, Rutherford NJ, Finch N, Soto-Ortolaza A, Lash J, Wider C, Wojtas A, DeJesus-Hernandez M, Adamson J. Mutations in the colony stimulating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroids. Nature Genetics. 2012; 44: 200-205Reitan, Ralph M. Trail Making Test: Manual for administration and scoring. Reitan Neuropsychology Laboratory 1992.Shapiro EG, Lipton ME, Krivit W. White matter dysfunction and its neuropsychological correlates: a longitudinal study of a case of metachromatic leukodystrophy treated with bone marrow transplant. J Clin Exp Neuropsychol 1992; 14: 610-624.Smith NJ, Marcus RE, Sahakian BJ, Kapur N, Cox TM. Haematopoietic stem cell transplantation does not retard disease progression in the psycho-cognitive variant of late-onset metachromatic leukodystrophy. J Inherit Metab Dis 2010; 33: 471-475Stroobants S, Leroy T, Eckhardt M, Aerts JM, Berckmans D, D?Hooge R. Early signs of neurolipidosis-related behavioural alterations in a murine model of metachromatic leukodystrophy. Behav Brain Res 2008: 189; 306-316.Weschsler D. Weschsler Memory Scale. The Psychological Corporation. 1972.Yesavage JA, Sheikh JI. 9/Geriatric depression scale (GDS) recent evidence and development of a shorter version. Clin Gerontol 1986; 5: 165-173.AtenciónFuncionamiento neurocognitivoFunciones ejecutivasMemoriaLeucodistrofia metacromáticaAttentionNeurocognitive FunctioningExecutive FunctionsMemoryMetachromatic LeukodystrophyNeuropsychiatric symptoms in a patient diagnosed in adulthood with Metachromatic Leukodystrophy: Case report of low incidence and prevalence in ColombiaArtículos Científicosinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_2df8fbb1http://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articleNINGUNAinfo:eu-repo/semantics/closedAccesshttp://purl.org/coar/access_right/c_14cbPublicationORIGINAL2019_Neuropsychiatric_symptoms.pdf2019_Neuropsychiatric_symptoms.pdfArtículoapplication/pdf943929https://repository.ucc.edu.co/bitstreams/3597a46e-07a1-4c3d-9710-80e28f6a52a3/download8f404167f7784e4f60f56b9888b0d783MD51LICENSElicense.txtlicense.txttext/plain; charset=utf-84334https://repository.ucc.edu.co/bitstreams/7bb37ab6-49e6-48fc-b375-70c07145d94b/download3bce4f7ab09dfc588f126e1e36e98a45MD53THUMBNAIL2019_Neuropsychiatric_symptoms.pdf.jpg2019_Neuropsychiatric_symptoms.pdf.jpgGenerated Thumbnailimage/jpeg5754https://repository.ucc.edu.co/bitstreams/70c22c4c-e67d-4e9e-ac1a-ffb55afca912/downloadfee8fada1d8ed7781650ef91340f2662MD54TEXT2019_Neuropsychiatric_symptoms.pdf.txt2019_Neuropsychiatric_symptoms.pdf.txtExtracted texttext/plain30604https://repository.ucc.edu.co/bitstreams/abb70cab-d986-4bb5-b61f-9d0525c700fa/download49b8b699a4c49a6022ec164e1f43eff9MD5520.500.12494/33682oai:repository.ucc.edu.co:20.500.12494/336822024-08-10 09:35:21.737restrictedhttps://repository.ucc.edu.coRepositorio Institucional Universidad Cooperativa de Colombiabdigital@metabiblioteca.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